Hospital, Diagnostic Center, Research and Veterinary Clinic is Increasing Demand of CT Scanner | Trends 2018

The report "CT Scanner Market by Type (Stationary, Portable), Architecture (C-arm, O-arm), Technology (High, Mid, Low Slice, CBCT), Application (Human, Veterinary, Research), End User (Hospital, Diagnostic Center, Research, Veterinary Clinic) - Global Forecast to 2022", analyzes and studies the major drivers, restraints, opportunities, and challenges of the CTscanners market in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Factors like growing need for effective and early diagnosis, rising global prevalence of targeted, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans, and technological advancements are driving the growth of the market.


Browse 61 market data tables and 51 figures spread through 175 pages and in-depth TOC on "CT Scanner Market ".
http://www.marketsandmarkets.com/Market-Reports/ct-scanner-market-184364345.html


On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets.



Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners.

For Further Inquiry: - https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=184364345

Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, which is primarily driven by growth in the aging U.S. population; an increasing public emphasis on minimally invasive & effective disease management strategies; robust reimbursement scenario; increasing adoption of novel applications; and rising public-private investments.